CHU de Besancon

Besançon 25030

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Colorectal Cancer, Coronary Artery Disease, Deep Venous Thrombosis, Endometrial Cancer, Endometrial Neoplasm, Heart Failure, Ovarian Cancer, Ovarian Cancer, Ovarian Neoplasms, Pulmonary Embolism, Rectal Cancer, Rectal Tumor, Rectal/Anal

Studies at this site

• GEN1047 for Solid Tumors - First in Human (FIH) Trial — Stopped early
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) — Running, not enrolling
• Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) — Completed
• SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study — Stopped early
• Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy — Completed
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed